Gerbrand van der Heden van Noort

Dr. Gerbrand van der Heden van Noort

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 July 2020 in Nature
Verified
Journal Article
Closed access
PDF file
DSDonghyuk Shin
Donghyuk Shin
RMRukmini Mukherjee
Rukmini Mukherjee
DGDiana Grewe
Diana Grewe
DBDenisa Bojkova
Denisa Bojkova
KBKheewoong Baek
Kheewoong Baek
IDIvan Dikic
Ivan Dikic

26 August 2020 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
TKTheresa Klemm
Theresa Klemm
GEGregor Ebert
Gregor Ebert
DCDale J Calleja
Dale J Calleja
CACody C Allison
Cody C Allison
LRLachlan W Richardson
Lachlan W Richardson
DKDavid Komander
David Komander
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.

1 May 2016 in Molecular Cell
Verified
Journal Article
Closed access
MBMiklós Békés
Miklós Békés
GNGerbrand van der Heden van Noort
Gerbrand van der Heden van Noort
REReggy Ekkebus
Reggy Ekkebus
HOHuib Ovaa
Huib Ovaa
THTony T. Huang
Tony T. Huang
CLChristopher D. Lima
Christopher D. Lima

1 April 2016 in Cell Chemical Biology
Verified
Journal Article
Open access
DFDennis Flierman
Dennis Flierman
GNGerbrand van der Heden van Noort
Gerbrand van der Heden van Noort
REReggy Ekkebus
Reggy Ekkebus
PGPaul P. Geurink
Paul P. Geurink
TMTycho Mevissen
Tycho Mevissen
HOHuib Ovaa
Huib Ovaa
Ubiquitin chains are important post-translational modifications that control a large number of cellular processes. Chains can be formed via different linkages, which determines the type of signal they convey. Deubiquitylating enzymes (DUBs) regulate ubiquitylation status by trimming or removing chains from attached proteins. DUBs can contain several ubiquitin-binding pockets, which confer specificity toward differently linked chains. Most tools for monitoring DUB specificity target binding pockets on opposing sides of the active site; however, some DUBs contain additional pockets. Therefore, reagents targeting additional pockets are essential to fully understand linkage specificity. We report the development of active site-directed probes and fluorogenic substrates, based on non-hydrolyzable diubiquitin, that are equipped with a C-terminal warhead or a fluorogenic activity reporter moiety. We demonstrate that various DUBs in lysates display differential reactivity toward differently linked diubiquitin probes, as exemplified by the proteasome-associated DUB USP14. In addition, OTUD2 and OTUD3 show remarkable linkage-specific reactivity with our diubiquitin-based reagents.

20 August 2012 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
RVRichard Virgen-Slane
Richard Virgen-Slane
JRJanet M. Rozovics
Janet M. Rozovics
KFKerry D. Fitzgerald
Kerry D. Fitzgerald
Tuan  NgoTuan Ngo
Tuan Ngo
WCWayne Chou
Wayne Chou
BSBert Semler
Bert Semler
A previously described mammalian cell activity, called VPg unlinkase, specifically cleaves a unique protein-RNA covalent linkage generated during the viral genomic RNA replication steps of a picornavirus infection. For over three decades, the identity of this cellular activity and its normal role in the uninfected cell had remained elusive. Here we report the purification and identification of VPg unlinkase as the DNA repair enzyme, 5'-tyrosyl-DNA phosphodiesterase-2 (TDP2). Our data show that VPg unlinkase activity in different mammalian cell lines correlates with their differential expression of TDP2. Furthermore, we show that recombinant TDP2 can cleave the protein-RNA linkage generated by different picornaviruses without impairing the integrity of viral RNA. Our results reveal a unique RNA repair-like function for TDP2 and suggest an unusual role in host-pathogen interactions for this cellular enzyme. On the basis of the identification of TDP2 as a potential antiviral target, our findings may lead to the development of universal therapeutics to treat the millions of individuals afflicted annually with diseases caused by picornaviruses, including myocarditis, aseptic meningitis, encephalitis, hepatitis, and the common cold.

16 March 2010 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
GNGerbrand van der Heden van Noort
Gerbrand van der Heden van Noort
MHMaarten G. van der Horst
Maarten G. van der Horst
HOHerman S. Overkleeft
Herman S. Overkleeft
GMGijsbert A. van der Marel
Gijsbert A. van der Marel
DFDmitri V. Filippov
Dmitri V. Filippov